AceLink Therap 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AL01211 / AceLink Therap
NCT06114329: Study of the Safety and Biologic Activity of AL01211 in Treatment Naive Males With Classic Fabry Disease

Recruiting
2
16
RoW
AL01211
AceLink Therapeutics, Inc., Tigermed Consulting Co., Ltd
Fabry Disease
12/24
06/26
ChiCTR2200061431: A randomized, double-blind, placebo-controlled, single-dose escalation and multi-dose escalation phase I clinical study investigating the safety, tolerability, and pharmacokinetic profile of AL01211 administered orally in healthy adult subjects in China

Not yet recruiting
1
30
 
D1 15 mg trial drug or placebo,oral single dose; D8 60 mg trial drug or placebo,oral single dose ;D1~D14, 30 mg trial drug or placebo, q.d. ;D1~D14, 60 mg trial drug or placebo, q.d.
The Second Hospital of Anhui Medical University; The Second Hospital of Anhui Medical University, Acelink (Suzhou) Biopharmaceutical Co. Ltd.
Fabry disease
 
 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AL01211 / AceLink Therap
NCT06114329: Study of the Safety and Biologic Activity of AL01211 in Treatment Naive Males With Classic Fabry Disease

Recruiting
2
16
RoW
AL01211
AceLink Therapeutics, Inc., Tigermed Consulting Co., Ltd
Fabry Disease
12/24
06/26
ChiCTR2200061431: A randomized, double-blind, placebo-controlled, single-dose escalation and multi-dose escalation phase I clinical study investigating the safety, tolerability, and pharmacokinetic profile of AL01211 administered orally in healthy adult subjects in China

Not yet recruiting
1
30
 
D1 15 mg trial drug or placebo,oral single dose; D8 60 mg trial drug or placebo,oral single dose ;D1~D14, 30 mg trial drug or placebo, q.d. ;D1~D14, 60 mg trial drug or placebo, q.d.
The Second Hospital of Anhui Medical University; The Second Hospital of Anhui Medical University, Acelink (Suzhou) Biopharmaceutical Co. Ltd.
Fabry disease
 
 

Download Options